Patents by Inventor Jifang WENG

Jifang WENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compounds, preparation methods therefor, and methods of uses thereof
    Patent number: 12173010
    Abstract: Provided herein are novel heterocyclic compounds, for example, compounds having Formula I. Also provided herein are methods of preparing the compounds and methods of using the same, for example, in inhibiting TGF-beta mediated signaling and/or for treating cancer.
    Type: Grant
    Filed: May 12, 2023
    Date of Patent: December 24, 2024
    Assignee: INVENTISBIO CO., LTD.
    Inventors: Xing Dai, Yaolin Wang, Yueheng Jiang, Yanqin Liu, Haotao Niu, Zhenwu Wang, Zixing Han, Liangshan Tao, Jifang Weng, Zhe Shi
  • PYRIDAZINONE OR PYRIDINONE COMPOUNDS, PREPARATION METHODS AND USES THEREOF
    Publication number: 20240343727
    Abstract: Provided herein are novel compounds, for example, compounds having a Formula (I), or a pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in treating cancer.
    Type: Application
    Filed: August 16, 2022
    Publication date: October 17, 2024
    Inventors: Xianhai HUANG, Younong YU, Haotao NIU, Hong YANG, Shanshan WANG, Jifang WENG, Yaolin WANG, Xing DAI
  • Heterocyclic compounds, preparation methods and uses thereof
    Patent number: 12110289
    Abstract: Provided herein are novel compounds, for example, compounds having a Formula (I) or Formula (II), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS G12C in a cell, and/or in treating various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (e.g., non-small cell lung cancer).
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: October 8, 2024
    Assignee: InventisBio Co., Ltd.
    Inventors: Xing Dai, Yaolin Wang, Yueheng Jiang, Yanqin Liu, Zhe Shi, Zhenwu Wang, Liangshan Tao, Zixing Han, Haotao Niu, Jifang Weng
  • HETEROARYL COMPOUNDS, PREPARATION METHODS AND USES THEREOF
    Publication number: 20240140929
    Abstract: Provided herein are novel compounds, for example, compounds having a Formula (I), or a pharmaceutically acceptable N salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting TYK2, and/or function of IL-12, IL-23 and/or INF-alpha, and/or in treating various associated diseases or disorders.
    Type: Application
    Filed: December 22, 2021
    Publication date: May 2, 2024
    Inventors: Xing DAI, Xianhai HUANG, Hong YANG, Zixing HAN, Haotao NIU, Jifang WENG, Zhe SHI, Yanqin LIU, Yueheng JIANG, Yaolin WANG
  • HETEROCYCLIC COMPOUNDS, PREPARATION METHODS THEREFOR, AND METHODS OF USES THEREOF
    Publication number: 20230357260
    Abstract: Provided herein are novel heterocyclic compounds, for example, compounds having Formula I. Also provided herein are methods of preparing the compounds and methods of using the same, for example, in inhibiting TGF-beta mediated signaling and/or for treating cancer.
    Type: Application
    Filed: May 12, 2023
    Publication date: November 9, 2023
    Inventors: Xing DAI, Yaolin WANG, Yueheng JIANG, Yanqin LIU, Haotao NIU, Zhenwu WANG, Zixing HAN, Liangshan TAO, Jifang WENG, Zhe SHI
  • HETEROARYL COMPOUNDS, PREPARATION METHODS AND USES THEREOF
    Publication number: 20230357233
    Abstract: Provided herein are novel compounds, for example, compounds having a Formula (I), Formula (A), Formula (II), Formula (III), Formula (IV), or Formula (V), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRASG12D in a cancer cell, and/or in treating various cancer such as pancreatic cancer, colorectal cancer, lung cancer (e.g., non-small cell lung cancer) or endometrial cancer.
    Type: Application
    Filed: August 26, 2021
    Publication date: November 9, 2023
    Inventors: Xing DAI, Hong YANG, Xianhai HUANG, Haotao NIU, Zixing HAN, Zhenwu WANG, Qiang ZHANG, Yanqin LIU, Yueheng JIANG, Liangshan TAO, Jifang WENG, Zhe SHI, Yaolin WANG
  • QUINAZOLINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF
    Publication number: 20230242544
    Abstract: Provided herein are novel compounds, for example, compounds having a Formula (I), Formula (II), or Formula (III), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRASG12D in a cancer cell, and/or in treating various cancer such as pancreatic cancer, colorectal cancer, lung cancer or endometrial cancer.
    Type: Application
    Filed: June 30, 2021
    Publication date: August 3, 2023
    Inventors: Xing DAI, Yaolin WANG, Yueheng JIANG, Haotao NIU, Yanqin LIU, Hong YANG, Zixing HAN, Zhenwu WANG, Liangshan TAO, Qiang ZHANG, Zhe SHI, Jifang WENG
  • Heterocyclic compounds, preparation methods therefor, and methods of uses thereof
    Patent number: 11691981
    Abstract: Provided herein are novel heterocyclic compounds, for example, compounds having Formula I. Also provided herein are methods of preparing the compounds and methods of using the same, for example, in inhibiting TGF-beta mediated signaling and/or for treating cancer.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: July 4, 2023
    Assignee: INVENTISBIO CO., LTD.
    Inventors: Xing Dai, Yaolin Wang, Yueheng Jiang, Yanqin Liu, Haotao Niu, Zhenwu Wang, Zixing Han, Liangshan Tao, Jifang Weng, Zhe Shi
  • HETEROCYCLIC COMPOUNDS, PREPARATION METHODS AND USES THEREOF
    Publication number: 20210355125
    Abstract: Provided herein are novel compounds, for example, compounds having a Formula (I) or Formula (II), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS G12C in a cell, and/or in treating various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (e.g., non-small cell lung cancer).
    Type: Application
    Filed: July 1, 2021
    Publication date: November 18, 2021
    Inventors: Xing DAI, Yaolin WANG, Yueheng JIANG, Yanqin LIU, Zhe SHI, Zhenwu WANG, Liangshan TAO, Zixing HAN, Haotao NIU, Jifang WENG
  • HETEROCYCLIC COMPOUNDS, PREPARATION AND METHODS AND USES THEREOF
    Publication number: 20210198255
    Abstract: Provided herein are novel compounds, for example, compounds having a Formula (I) or Formula (II), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS G12C in a cell, and/or in treating various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (e.g., non-small cell lung cancer).
    Type: Application
    Filed: February 10, 2021
    Publication date: July 1, 2021
    Inventors: Xing DAI, Yaolin WANG, Yueheng JIANG, Yanqin LIU, Zhe SHI, Zhenwu WANG, Liangshan TAO, Zixing HAN, Haotao NIU, Jifang WENG
  • HETEROCYCLIC COMPOUNDS, PREPARATION METHODS THEREFOR, AND METHODS OF USES THEREOF
    Publication number: 20210017187
    Abstract: Provided herein are novel heterocyclic compounds, for example, compounds having Formula I. Also provided herein are methods of preparing the compounds and methods of using the same, for example, in inhibiting TGF-beta mediated signaling and/or for treating cancer.
    Type: Application
    Filed: June 24, 2020
    Publication date: January 21, 2021
    Inventors: Xing DAI, Yaolin WANG, Yueheng JIANG, Yanqin LIU, Haotao NIU, Zhenwu WANG, Zixing HAN, Liangshan TAO, Jifang WENG, Zhe SHI